Zimmer Biomet Holdings, Inc. ZBH

91.04 1.35 1.51% as of 25 Sep
Market cap
$17.1B
P/E
22.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Zimmer Biomet Holdings, Inc. (ZBH) P/E ratio

As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/E ratio of 22.0×. Over the past ten years it has ranged from 0.0× (March 2021) to 708× (September 2020); the current reading is higher than 27% of that period. That is in line with the Medical Devices industry median of 22.2× and in line with the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 25.2× 6.11%
FY2024 23.7× (3.99%)
FY2023 24.7× (78.63%)
FY2022 116× 81.06%
FY2021 63.9× —
FY2020 0.0× —
FY2019 26.4× —
FY2018 0.0× —
FY2017 13.2× (80.34%)
FY2016 67.3× (38.54%)

Quarterly

Period P/E ratio Change
Jun 2026 20.8× (10.78%)
Mar 2026 23.4× (7.24%)
Dec 2025 25.2× 3.82%
Sep 2025 24.3× 9.59%
42 more quarters

Against its own ten years

Low 0.0× High 708×
Ten-year median 28.1×
Current reading's percentile 27

P/E ratio against peers

Company P/E ratio
GEHC GE HealthCare Technologies Inc. compare 15.3×
PHG Koninklijke Philips N.V. compare 18.2×
GMED Globus Medical, Inc. compare 18.8×
ZBH Zimmer Biomet Holdings, Inc. 22.0×
STE STERIS plc compare 25.4×
SNN Smith & Nephew SNATS, Inc. compare 32.8×
BIO.B Bio-Rad Laboratories, Inc. compare 43.8×
BIO Bio-Rad Laboratories, Inc. compare 45.7×
PEN Penumbra, Inc. compare 78.0×
Medical Devices industry median 22.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ZBH